Core Laboratories (CLB) Stock Price, News & Analysis

Company Overview

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation.

Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.

Key Stats

• Today's Range: $12.29 to $12.85
• 50-Day Range: $9.87 to $13.48
• 52-Week Range: $9.79 to $20.36
• Volume: 474,992 shs
• Average Volume: 745,057 shs
• Market Capitalization: $572.60 million
• P/E Ratio: 22.28
• Dividend Yield: 0.32%
• Price Target: $21.00
• Consensus Rating: Moderate Buy

Core Laboratories Stock Analysis - MarketRank™

Core Laboratories scored higher than 89% of companies evaluated by MarketBeat, and ranked 46th out of 251 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Core Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

Core Laboratories has a consensus price target of $21.00, representing about 68.3% upside from its current price of $12.48.

Amount of Analyst Coverage

Core Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 49.06%

Earnings Growth

Earnings for Core Laboratories are expected to grow by 49.06% in the coming year, from $0.53 to $0.79 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Core Laboratories is 22.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.63.

Price to Earnings Ratio vs. Sector

The P/E ratio of Core Laboratories is 22.28, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 20.24.

Price to Earnings Growth Ratio

Core Laboratories has a PEG Ratio of 3.00. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Core Laboratories has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.26% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 5.02.

Change versus previous month

Short interest in Core Laboratories has recently increased by 4.24%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Core Laboratories has a dividend yield of 0.32%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Core Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.86

News Sentiment

Core Laboratories has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Energy companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Core Laboratories this week, compared to 2 articles on an average week.

MarketBeat Follows

2 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.9 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $53,900.00 in company stock, which represents 0.0094% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $53,900.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.26% of the stock of Core Laboratories is held by insiders.

Percentage Held by Institutions

97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 6/1 Dividend: 5/11/2026
• Ex-Dividend for 6/1 Dividend: 5/11/2026
• Dividend Payable: 6/01/2026
• Last Earnings: 7/29/2026
• Record date for 8/31 Dividend: 8/10/2026
• Ex-Dividend for 8/31 Dividend: 8/10/2026
• Today: 8/16/2026
• Dividend Payable: 8/31/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Energy
• Industry: Energy Equipment & Services
• Sub-Industry: Oil & Gas Equipment & Services
• Current Symbol: NYSE:CLB
• CIK: 1958086
• Web: www.corelab.com
• Phone: (713) 328-2673
• Fax: N/A
• Employees: 3,300
• Year Founded: 1936

Price Target and Rating

• Average Price Target for Core Laboratories: $21.00
• High Price Target: $21.00
• Low Price Target: $21.00
• Potential Upside/Downside: +68.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.56
• Trailing P/E Ratio: 22.28
• Forward P/E Ratio: 23.55
• P/E Growth: 3
• Net Income: $29.67 million
• Net Margins: 5.10%
• Pretax Margin: 7.09%
• Return on Equity: 10.03%
• Return on Assets: 4.71%

Debt

• Debt-to-Equity Ratio: 0.41
• Current Ratio: 2.12
• Quick Ratio: 1.55

Sales & Book Value

• Annual Sales: $519.18 million
• Price / Sales: 1.10
• Cash Flow: $1.07 per share
• Price / Cash Flow: 11.65
• Book Value: $6.08 per share
• Price / Book: 2.05

Miscellaneous

• Outstanding Shares: 45,885,000
• Free Float: 45,307,000
• Market Cap: $572.60 million
• Optionable: Optionable
• Beta: 1.03